-
1
-
-
84855396777
-
Executive summary: Heart disease and stroke statistics-2012 update: A report from the American Heart Association
-
Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012;125:188-97.
-
(2012)
Circulation
, vol.125
, pp. 188-197
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
-
2
-
-
0038706687
-
Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:143-3421.
-
(2002)
Circulation
, vol.106
, pp. 143-3421
-
-
-
3
-
-
0019192770
-
The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases
-
Margolis JR, Chen JT, Kong Y, et al. The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology 1980;137:609-16.
-
(1980)
Radiology
, vol.137
, pp. 609-616
-
-
Margolis, J.R.1
Chen, J.T.2
Kong, Y.3
-
4
-
-
0028910752
-
Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram. Effect of patient's sex on diagnosis
-
Rumberger JA, Sheedy PF III, Breen JF, et al. Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram. Effect of patient's sex on diagnosis. Circulation 1995;91:1363-67.
-
(1995)
Circulation
, vol.91
, pp. 1363-1367
-
-
Rumberger, J.A.1
Sheedy III, P.F.2
Breen, J.F.3
-
5
-
-
9044240472
-
Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study
-
Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study. Circulation 1996;93:898-904.
-
(1996)
Circulation
, vol.93
, pp. 898-904
-
-
Budoff, M.J.1
Georgiou, D.2
Brody, A.3
-
6
-
-
0035953113
-
Electron-beam computed tomography in the diagnosis of coronary artery disease: A meta-Analysis
-
Nallamothu BK, Saint S, Bielak LF, et al. Electron-beam computed tomography in the diagnosis of coronary artery disease: A meta-Analysis. Arch Intern Med 2001;161:833-38.
-
(2001)
Arch Intern Med
, vol.161
, pp. 833-838
-
-
Nallamothu, B.K.1
Saint, S.2
Bielak, L.F.3
-
7
-
-
0035137052
-
Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: Results of 1,764 patients
-
Haberl R, Becker A, Leber A, et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: Results of 1,764 patients. J Am Coll Cardiol 2001;37:451-57.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 451-457
-
-
Haberl, R.1
Becker, A.2
Leber, A.3
-
8
-
-
0025342374
-
Quantification of coronary artery calcium using ultrafast computed tomography
-
Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
-
(1990)
J Am Coll Cardiol
, vol.15
, pp. 827-832
-
-
Agatston, A.S.1
Janowitz, W.R.2
Hildner, F.J.3
-
9
-
-
41449112372
-
Coronary calcium as a predictor of coronary events in four racial or ethnic groups
-
Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-45.
-
(2008)
N Engl J Med
, vol.358
, pp. 1336-1345
-
-
Detrano, R.1
Guerci, A.D.2
Carr, J.J.3
-
10
-
-
82455212893
-
Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: Results from the CONFIRM (coronary CT angiography evaluation for clinical outcomes: An international multicenter) registry
-
Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: Results from the CONFIRM (coronary CT angiography evaluation for clinical outcomes: An international multicenter) registry. J Am Coll Cardiol 2011;58:2533-40.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 2533-2540
-
-
Villines, T.C.1
Hulten, E.A.2
Shaw, L.J.3
-
11
-
-
66449095849
-
Diagnostic and prognostic value of absence of coronary artery calcification
-
Sarwar A, Shaw LJ, Shapiro MD, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009;2:675-88.
-
(2009)
JACC Cardiovasc Imaging
, vol.2
, pp. 675-688
-
-
Sarwar, A.1
Shaw, L.J.2
Shapiro, M.D.3
-
12
-
-
33644865949
-
Distribution of coronary artery calcium by race, gender, and age: Results from the multiethnic study of atherosclerosis (MESA)
-
McClelland RL, Chung H, Detrano R, et al. Distribution of coronary artery calcium by race, gender, and age: Results from the multiethnic study of atherosclerosis (MESA). Circulation 2006;113:30-7.
-
(2006)
Circulation
, vol.113
, pp. 30-37
-
-
McClelland, R.L.1
Chung, H.2
Detrano, R.3
-
13
-
-
84858306926
-
Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study
-
Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study. Ann Intern Med 2012;156:438-44.
-
(2012)
Ann Intern Med
, vol.156
, pp. 438-444
-
-
Kavousi, M.1
Elias-Smale, S.2
Rutten, J.H.3
-
14
-
-
34247546061
-
Long-Term prognosis associated with coronary calcification: Observations from a registry of 25,253 patients
-
Budoff MJ, Shaw LJ, Liu ST, et al. Long-Term prognosis associated with coronary calcification: Observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1860-1870
-
-
Budoff, M.J.1
Shaw, L.J.2
Liu, S.T.3
-
15
-
-
77951639385
-
Coronary artery calcium score and risk classification for coronary heart disease prediction
-
Polonsky TS,McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010;303:1610-16.
-
(2010)
JAMA
, vol.303
, pp. 1610-1616
-
-
Polonsky, T.S.1
McClelland, R.L.2
Jorgensen, N.W.3
-
16
-
-
0037512312
-
Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5635 initially asymptomatic low-To intermediate-risk adults
-
Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5635 initially asymptomatic low-To intermediate-risk adults. Circulation 2003;107:2571-76.
-
(2003)
Circulation
, vol.107
, pp. 2571-2576
-
-
Kondos, G.T.1
Hoff, J.A.2
Sevrukov, A.3
-
17
-
-
0347722500
-
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals
-
Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-15.
-
(2004)
JAMA
, vol.291
, pp. 210-215
-
-
Greenland, P.1
LaBree, L.2
Azen, S.P.3
-
18
-
-
0029949496
-
Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects
-
Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-53.
-
(1996)
Circulation
, vol.93
, pp. 1951-1953
-
-
Arad, Y.1
Spadaro, L.A.2
Goodman, K.3
-
19
-
-
20444373191
-
Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis heart study
-
Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 158-165
-
-
Arad, Y.1
Goodman, K.J.2
Roth, M.3
-
20
-
-
27644504593
-
Detection of high-risk young adults and women by coronary calcium and national cholesterol education program panel iii guidelines
-
Nasir K, Michos ED, Blumenthal RS, et al. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol 2005; 46:1931-36.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1931-1936
-
-
Nasir, K.1
Michos, E.D.2
Blumenthal, R.S.3
-
21
-
-
37149016813
-
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: The multi-ethnic study of atherosclerosis (MESA)
-
Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: The multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 2007;167:2437-42.
-
(2007)
Arch Intern Med
, vol.167
, pp. 2437-2442
-
-
Lakoski, S.G.1
Greenland, P.2
Wong, N.D.3
-
22
-
-
84655169207
-
Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: A systematic review
-
Peters SA, den Ruijter HM, Bots ML, et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: A systematic review. Heart 2012;98:177-84.
-
(2012)
Heart
, vol.98
, pp. 177-184
-
-
Peters, S.A.1
Den Ruijter, H.M.2
Bots, M.L.3
-
23
-
-
20444407053
-
Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial
-
Arad Y, Spadaro LA, Roth M, et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005;46:166-72.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 166-172
-
-
Arad, Y.1
Spadaro, L.A.2
Roth, M.3
-
24
-
-
84858325566
-
Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treat-ment: A post hoc analysis from the st francis heart study
-
Mulders TA, Sivapalaratnam S, Stroes ES, et al. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treat-ment: A post hoc analysis from the St. Francis Heart Study. JACC Cardiovasc Imaging 2012;5:252-60.
-
(2012)
JACC Cardiovasc Imaging
, vol.5
, pp. 252-260
-
-
Mulders, T.A.1
Sivapalaratnam, S.2
Stroes, E.S.3
-
25
-
-
3042817122
-
Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterollowering therapy
-
Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterollowering therapy. Arterioscler Thromb Vasc Biol 2004;24:1272-77.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1272-1277
-
-
Raggi, P.1
Callister, T.Q.2
Shaw, L.J.3
-
26
-
-
84865320778
-
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals
-
Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012;308:788-95.
-
(2012)
JAMA
, vol.308
, pp. 788-795
-
-
Yeboah, J.1
McClelland, R.L.2
Polonsky, T.S.3
-
27
-
-
33645464935
-
Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers
-
Shaw LJ, Raggi P, Callister TQ, et al. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J 2006;27:968-75.
-
(2006)
Eur Heart J
, vol.27
, pp. 968-975
-
-
Shaw, L.J.1
Raggi, P.2
Callister, T.Q.3
-
28
-
-
79956118515
-
Coronary calcium score and prediction of all-cause mortality in diabetes: The diabetes heart study
-
Agarwal S, Morgan T, Herrington DM, et al. Coronary calcium score and prediction of all-cause mortality in diabetes: The diabetes heart study. Diabetes Care 2011;34:1219-24.
-
(2011)
Diabetes Care
, vol.34
, pp. 1219-1224
-
-
Agarwal, S.1
Morgan, T.2
Herrington, D.M.3
-
29
-
-
78650041424
-
2010 accf/aha guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
-
Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56: E50-103.
-
(2010)
J Am Coll Cardiol
, vol.56
-
-
Greenland, P.1
Alpert, J.S.2
Beller, G.A.3
-
30
-
-
84856284437
-
Interpreting the coronary-Artery calcium score
-
Grayburn PA. Interpreting the coronary-Artery calcium score. N Engl J Med 2012;366:294-6.
-
(2012)
N Engl J Med
, vol.366
, pp. 294-296
-
-
Grayburn, P.A.1
-
31
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hansson, G.K.1
-
32
-
-
70450189795
-
Inflammation in atherosclerosis: From pathophysiology to practice
-
Leducq Transatlantic Network on Atherothrombosis.
-
Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2129-2138
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
33
-
-
81255188900
-
Atherosclerosis: Current pathogenesis and therapeutic options
-
Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 2011;17:1410-22.
-
(2011)
Nat Med
, vol.17
, pp. 1410-1422
-
-
Weber, C.1
Noels, H.2
-
34
-
-
26044483536
-
C-reactive protein: Ligands, receptors and role in inflammation
-
Marnell L, Mold C, Du Clos TW. C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-11.
-
(2005)
Clin Immunol
, vol.117
, pp. 104-111
-
-
Marnell, L.1
Mold, C.2
Du Clos, T.W.3
-
35
-
-
79952069515
-
Meta-Analysis of genomewide association studies in .80,000 subjects identifies multiple loci for C-reactive protein levels
-
Dehghan A, Dupuis J, Barbalic M, et al. Meta-Analysis of genomewide association studies in .80,000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011;123:731-8.
-
(2011)
Circulation
, vol.123
, pp. 731-738
-
-
Dehghan, A.1
Dupuis, J.2
Barbalic, M.3
-
36
-
-
67649961412
-
Genetic loci associated with C-reactive protein levels and risk of coronary heart disease
-
Elliott P, Chambers JC, Zhang W, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009;302:37-48.
-
(2009)
JAMA
, vol.302
, pp. 37-48
-
-
Elliott, P.1
Chambers, J.C.2
Zhang, W.3
-
37
-
-
55249087635
-
Genetically elevated C-reactive protein and ischemic vascular disease
-
Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008; 359:1897-1908.
-
(2008)
N Engl J Med
, vol.359
, pp. 1897-1908
-
-
Zacho, J.1
Tybjaerg-Hansen, A.2
Jensen, J.S.3
-
38
-
-
0037469232
-
Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the american heart association
-
Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
-
(2003)
Circulation
, vol.107
, pp. 499-511
-
-
Pearson, T.A.1
Mensah, G.A.2
Alexander, R.W.3
-
39
-
-
22844432451
-
Race and gender differences in C-reactive protein levels
-
Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46:464-9.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 464-469
-
-
Khera, A.1
McGuire, D.K.2
Murphy, S.A.3
-
40
-
-
78649342368
-
Ancestry as a determinant of mean population C-reactive protein values: Implications for cardiovascular risk prediction
-
Shah T, Newcombe P, Smeeth L, et al. Ancestry as a determinant of mean population C-reactive protein values: Implications for cardiovascular risk prediction. Circ Cardiovasc Genet 2010;3:436-44.
-
(2010)
Circ Cardiovasc Genet
, vol.3
, pp. 436-444
-
-
Shah, T.1
Newcombe, P.2
Smeeth, L.3
-
41
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-79.
-
(1997)
N Engl J Med
, vol.336
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
-
42
-
-
0032566401
-
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
-
Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
-
(1998)
Circulation
, vol.98
, pp. 731-733
-
-
Ridker, P.M.1
Buring, J.E.2
Shih, J.3
-
43
-
-
1842587885
-
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
-
Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
-
(2004)
N Engl J Med
, vol.350
, pp. 1387-1397
-
-
Danesh, J.1
Wheeler, J.G.2
Hirschfield, G.M.3
-
44
-
-
1642277853
-
C-reactive protein modulates risk prediction based on the Framingham score: Implications for future risk assessment: Results from a large cohort study in southern Germany
-
Koenig W, Lowel H, Baumert J, et al. C-reactive protein modulates risk prediction based on the Framingham score: Implications for future risk assessment: Results from a large cohort study in southern Germany. Circulation 2004;109:1349-53.
-
(2004)
Circulation
, vol.109
, pp. 1349-1353
-
-
Koenig, W.1
Lowel, H.2
Baumert, J.3
-
45
-
-
21844451117
-
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The cardiovascular health study
-
Cushman M, Arnold AM, Psaty BM, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The cardiovascular health study. Circulation 2005;112:25-31.
-
(2005)
Circulation
, vol.112
, pp. 25-31
-
-
Cushman, M.1
Arnold, A.M.2
Psaty, B.M.3
-
46
-
-
59649121465
-
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study
-
Wilson PW, Pencina M, Jacques P, et al. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008;1:92-7.
-
(2008)
Circ Cardiovasc Qual Outcomes
, vol.1
, pp. 92-97
-
-
Wilson, P.W.1
Pencina, M.2
Jacques, P.3
-
47
-
-
84867164377
-
C-reactive protein, fibrinogen, and cardiovascular disease prediction
-
Emerging Risk Factors Collaboration
-
Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20.
-
(2012)
N Engl J Med
, vol.367
, pp. 1310-1320
-
-
Kaptoge, S.1
Di Angelantonio, E.2
-
48
-
-
0032568486
-
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
-
Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11.
-
(1998)
Circulation
, vol.97
, pp. 2007-2011
-
-
Ridker, P.M.1
Glynn, R.J.2
Hennekens, C.H.3
-
49
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
-
50
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
-
(2002)
N Engl J Med
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
-
51
-
-
0037190065
-
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative observational study
-
Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-7.
-
(2002)
JAMA
, vol.288
, pp. 980-987
-
-
Pradhan, A.D.1
Manson, J.E.2
Rossouw, J.E.3
-
52
-
-
19944429519
-
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
-
Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005;352:29-38.
-
(2005)
N Engl J Med
, vol.352
, pp. 29-38
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Schoenhagen, P.3
-
53
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
JUPITER Study Group
-
Ridker PM, Danielson E, Fonseca FA, et al JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
54
-
-
77958507050
-
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate-And lowcardiovascular-risk individuals for statin therapy
-
Lee KK, Cipriano LE, Owens DK, et al. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate-And lowcardiovascular-risk individuals for statin therapy. Circulation 2010; 122:1478-87.
-
(2010)
Circulation
, vol.122
, pp. 1478-1487
-
-
Lee, K.K.1
Cipriano, L.E.2
Owens, D.K.3
-
55
-
-
0023636242
-
CDNA sequence of human apolipoprotein(a) is homologous to plasminogen
-
McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330:132-7.
-
(1987)
Nature
, vol.330
, pp. 132-137
-
-
McLean, J.W.1
Tomlinson, J.E.2
Kuang, W.J.3
-
56
-
-
0030451016
-
Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans
-
Marcovina SM, Albers JJ, Wijsman E, et al. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res 1996;37:2569-85.
-
(1996)
J Lipid Res
, vol.37
, pp. 2569-2585
-
-
Marcovina, S.M.1
Albers, J.J.2
Wijsman, E.3
-
57
-
-
0026667073
-
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations
-
Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992;90:52-60.
-
(1992)
J Clin Invest
, vol.90
, pp. 52-60
-
-
Boerwinkle, E.1
Leffert, C.C.2
Lin, J.3
-
58
-
-
73549097512
-
Genetic variants associated with Lp(a) lipoprotein level and coronary disease
-
Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361:2518-28.
-
(2009)
N Engl J Med
, vol.361
, pp. 2518-2528
-
-
Clarke, R.1
Peden, J.F.2
Hopewell, J.C.3
-
59
-
-
79551551096
-
Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans
-
Deo RC, Wilson JG, Xing C, et al. Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans. PLoS One 2011;6:e14581.
-
(2011)
PLoS One
, vol.6
-
-
Deo, R.C.1
Wilson, J.G.2
Xing, C.3
-
60
-
-
0242331117
-
Report of the national heart Lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: Recent advances and future directions
-
Marcovina SM, Koschinsky ML, Albers JJ, et al. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent advances and future directions. Clin Chem 2003;49:1785-96.
-
(2003)
Clin Chem
, vol.49
, pp. 1785-1796
-
-
Marcovina, S.M.1
Koschinsky, M.L.2
Albers, J.J.3
-
61
-
-
67651210632
-
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
-
Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009;302:412-23.
-
(2009)
JAMA
, vol.302
, pp. 412-423
-
-
Emerging Risk Factors Collaboration Erqou, S.1
Kaptoge, S.2
-
62
-
-
38049177286
-
Extreme lipoprotein (a) levels and risk of myocardial infarction in the general population: The Copenhagen City Heart Study
-
Kamstrup PR, Benn M, Tybjaerg-Hansen A, et al. Extreme lipoprotein (a) levels and risk of myocardial infarction in the general population: The Copenhagen City Heart Study. Circulation 2008;117:176-84.
-
(2008)
Circulation
, vol.117
, pp. 176-184
-
-
Kamstrup, P.R.1
Benn, M.2
Tybjaerg-Hansen, A.3
-
63
-
-
41549133097
-
Lipoprotein(a) levels and risk of future coronary heart disease: Large-scale prospective data
-
Bennet A, Di Angelantonio E, Erqou S, et al. Lipoprotein(a) levels and risk of future coronary heart disease: Large-scale prospective data. Arch Intern Med 2008;168:598-608.
-
(2008)
Arch Intern Med
, vol.168
, pp. 598-608
-
-
Bennet, A.1
Di Angelantonio, E.2
Erqou, S.3
-
64
-
-
0033558250
-
Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease
-
Dangas G, Ambrose JA, D'Agate DJ, et al. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. Am J Cardiol 1999;83:583-5.
-
(1999)
Am J Cardiol
, vol.83
, pp. 583-585
-
-
Dangas, G.1
Ambrose, J.A.2
D'Agate, D.J.3
-
65
-
-
84865120887
-
Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: A rationale for increased efforts to understand its pathophysiology and develop targeted therapies
-
Tsimikas S, Hall JL. Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: A rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll Cardiol 2012;60:716-21.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 716-721
-
-
Tsimikas, S.1
Hall, J.L.2
-
66
-
-
84865125773
-
Apolipoprotein (a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism
-
Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Apolipoprotein (a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012;60:722-9.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 722-729
-
-
Helgadottir, A.1
Gretarsdottir, S.2
Thorleifsson, G.3
-
67
-
-
84862502750
-
Lipid-related markers and cardiovascular disease prediction
-
Emerging Risk Factors Collaboration
-
Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, et al. Lipid-related markers and cardiovascular disease prediction. JAMA 2012;307:2499-506.
-
(2012)
JAMA
, vol.307
, pp. 2499-2506
-
-
Di Angelantonio, E.1
Gao, P.2
-
68
-
-
33748904095
-
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women
-
Suk Danik J, Rifai N, Buring JE, et al. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 2006;296:1363-70.
-
(2006)
JAMA
, vol.296
, pp. 1363-1370
-
-
Suk Danik, J.1
Rifai, N.2
Buring, J.E.3
-
69
-
-
84856101806
-
Associations between lipoprotein (a) levels and cardiovascular outcomes in black and white subjects: The atherosclerosis risk in communities (aric) study
-
Virani SS, Brautbar A, Davis BC, et al. Associations between lipoprotein (a) levels and cardiovascular outcomes in black and white subjects: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2012;125:241-9.
-
(2012)
Circulation
, vol.125
, pp. 241-249
-
-
Virani, S.S.1
Brautbar, A.2
Davis, B.C.3
-
70
-
-
0034708959
-
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol niaspan-gemfibrozil study group
-
Guyton JR, Blazing MA, Hagar J, et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med 2000; 160:1177-84.
-
(2000)
Arch Intern Med
, vol.160
, pp. 1177-1184
-
-
Guyton, J.R.1
Blazing, M.A.2
Hagar, J.3
-
71
-
-
84861309590
-
Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups
-
Bays HE, Shah A, Lin J, et al. Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups. Am J Cardiovasc Drugs 2012;12:197-206.
-
(2012)
Am J Cardiovasc Drugs
, vol.12
, pp. 197-206
-
-
Bays, H.E.1
Shah, A.2
Lin, J.3
-
72
-
-
33847005410
-
Apheresis in coronary heart disease with elevated Lp (a): A review of Lp (a) as a risk factor and its management
-
Keller C. Apheresis in coronary heart disease with elevated Lp (a): A review of Lp (a) as a risk factor and its management. Ther Apher Dial 2007;11:2-8.
-
(2007)
Ther Apher Dial
, vol.11
, pp. 2-8
-
-
Keller, C.1
-
73
-
-
0029103672
-
Familial Hypercholesterolaemia Regression Study: A randomised trial of low-densitylipoprotein apheresis
-
Thompson GR, Maher VM, Matthews S, et al. Familial Hypercholesterolaemia Regression Study: A randomised trial of low-densitylipoprotein apheresis. Lancet 1995;345:811-6.
-
(1995)
Lancet
, vol.345
, pp. 811-816
-
-
Thompson, G.R.1
Maher, V.M.2
Matthews, S.3
-
74
-
-
0043169544
-
Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia
-
van Wissen S, Smilde TJ, Trip MD, et al. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia. Heart 2003;89:893-6.
-
(2003)
Heart
, vol.89
, pp. 893-896
-
-
Van Wissen, S.1
Smilde, T.J.2
Trip, M.D.3
-
75
-
-
0036802128
-
Atorvastatin lowers lipoprotein (a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk
-
Gonbert S, Malinsky S, Sposito AC, et al. Atorvastatin lowers lipoprotein (a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. Atherosclerosis 2002;164: 305-11.
-
(2002)
Atherosclerosis
, vol.164
, pp. 305-311
-
-
Gonbert, S.1
Malinsky, S.2
Sposito, A.C.3
-
76
-
-
79955066200
-
Effect of atorvastatin on lipoprotein (a) and interleukin-10: A randomized placebo-controlled trial
-
Hernandez C, Francisco G, Ciudin A, et al. Effect of atorvastatin on lipoprotein (a) and interleukin-10: A randomized placebo-controlled trial. Diabetes Metab 2011;37:124-30.
-
(2011)
Diabetes Metab
, vol.37
, pp. 124-130
-
-
Hernandez, C.1
Francisco, G.2
Ciudin, A.3
-
77
-
-
4544346640
-
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial
-
Tsimikas S, Witztum JL, Miller ER, et al. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation 2004;110: 1406-12.
-
(2004)
Circulation
, vol.110
, pp. 1406-1412
-
-
Tsimikas, S.1
Witztum, J.L.2
Miller, E.R.3
-
78
-
-
0036803259
-
Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects
-
Schaefer EJ, McNamara JR, Tayler T, et al. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 2002;90:689-96.
-
(2002)
Am J Cardiol
, vol.90
, pp. 689-696
-
-
Schaefer, E.J.1
McNamara, J.R.2
Tayler, T.3
-
79
-
-
84855849500
-
Atorvastatin decreases lipoprotein(a): A metaanalysis of randomized trials
-
Takagi H, Umemoto T. Atorvastatin decreases lipoprotein(a): A metaanalysis of randomized trials. Int J Cardiol 2012;154:183-6.
-
(2012)
Int J Cardiol
, vol.154
, pp. 183-186
-
-
Takagi, H.1
Umemoto, T.2
-
80
-
-
84860271201
-
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: Importance of Lp(a)
-
Deshmukh HA, Colhoun HM, Johnson T, et al. Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: Importance of Lp(a). J Lipid Res 2012;53:1000-11.
-
(2012)
J Lipid Res
, vol.53
, pp. 1000-1011
-
-
Deshmukh, H.A.1
Colhoun, H.M.2
Johnson, T.3
-
81
-
-
38849179382
-
Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the diabetes and combined lipid therapy regimen study)
-
May HT, Anderson JL, Pearson RR, et al. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study). Am J Cardiol 2008;101:486-9.
-
(2008)
Am J Cardiol
, vol.101
, pp. 486-489
-
-
May, H.T.1
Anderson, J.L.2
Pearson, R.R.3
-
82
-
-
79953699040
-
Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice
-
Merki E, Graham M, Taleb A, et al. Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice. J Am Coll Cardiol 2011;57:1611-21.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1611-1621
-
-
Merki, E.1
Graham, M.2
Taleb, A.3
-
83
-
-
80052380574
-
Farnesoid X receptor represses hepatic human APOA gene expression
-
Chennamsetty I, Claudel T, Kostner KM, et al. Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest 2011;121:3724-34.
-
(2011)
J Clin Invest
, vol.121
, pp. 3724-3734
-
-
Chennamsetty, I.1
Claudel, T.2
Kostner, K.M.3
-
84
-
-
78649888517
-
Lipoprotein(a) as a cardiovascular risk factor: Current status
-
Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: Current status. Eur Heart J 2010;31:2844-53.
-
(2010)
Eur Heart J
, vol.31
, pp. 2844-2853
-
-
Nordestgaard, B.G.1
Chapman, M.J.2
Ray, K.3
-
85
-
-
80053914425
-
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
-
Davidson MH, Ballantyne CM, Jacobson TA, et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists. J Clin Lipidol 2011;5:338-67.
-
(2011)
J Clin Lipidol
, vol.5
, pp. 338-367
-
-
Davidson, M.H.1
Ballantyne, C.M.2
Jacobson, T.A.3
-
86
-
-
0032519844
-
The role of carotid arterial intima-media thickness in predicting clinical coronary events
-
Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
-
(1998)
Ann Intern Med
, vol.128
, pp. 262-269
-
-
Hodis, H.N.1
Mack, W.J.2
LaBree, L.3
-
87
-
-
33846609195
-
Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-Analysis
-
Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-Analysis. Circulation 2007;115:459-67.
-
(2007)
Circulation
, vol.115
, pp. 459-467
-
-
Lorenz, M.W.1
Markus, H.S.2
Bots, M.L.3
-
88
-
-
84894169031
-
Effect of statin therapy on the progression of common carotid artery intima-media thickness: An updated systematic review and meta-Analysis of randomized controlled trials
-
In press
-
Huang Y, Li W, Dong L, et al. Effect of statin therapy on the progression of common carotid artery intima-media thickness: An updated systematic review and meta-Analysis of randomized controlled trials. J Atheroscler Thromb In press.
-
J Atheroscler Thromb
-
-
Huang, Y.1
Li, W.2
Dong, L.3
-
89
-
-
77956864643
-
Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal-medial thickness: A meta-Analysis of randomized controlled trials
-
Bedi US, Singh M, Singh PP, et al. Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal-medial thickness: A meta-Analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther 2010;15:268-73.
-
(2010)
J Cardiovasc Pharmacol Ther
, vol.15
, pp. 268-273
-
-
Bedi, U.S.1
Singh, M.2
Singh, P.P.3
-
90
-
-
84865312335
-
Common carotid intima-media thickness measurements in cardiovascular risk prediction: A meta-Analysis
-
Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: A meta-Analysis. JAMA 2012;308:796-803.
-
(2012)
JAMA
, vol.308
, pp. 796-803
-
-
Den Ruijter, H.M.1
Peters, S.A.2
Anderson, T.J.3
-
91
-
-
0033533527
-
Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
-
Eikelboom JW, Lonn E, Genest J Jr, et al. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75.
-
(1999)
Ann Intern Med
, vol.131
, pp. 363-375
-
-
Eikelboom, J.W.1
Lonn, E.2
Genest Jr., J.3
-
92
-
-
0037164375
-
Homocysteine and cardiovascular disease: Evidence on causality from a meta-Analysis
-
Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta-Analysis. BMJ 2002;325:1202.
-
(2002)
BMJ
, vol.325
, pp. 1202
-
-
Wald, D.S.1
Law, M.2
Morris, J.K.3
-
93
-
-
0037164104
-
Homocysteine and risk of ischemic heart disease and stroke: A meta-Analysis
-
Homocysteine Studies Collaboration.
-
Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-Analysis. JAMA 2002;288: 2015-22.
-
(2002)
JAMA
, vol.288
, pp. 2015-2022
-
-
-
94
-
-
0028901371
-
Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease
-
Mansoor MA, Bergmark C, Svardal AM, et al. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995;15: 232-40.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 232-240
-
-
Mansoor, M.A.1
Bergmark, C.2
Svardal, A.M.3
-
95
-
-
0035810980
-
Homocysteine induces expression and secretion of monocyte chemoattractant protein-And interleukin-8 in human aortic endothelial cells: Implications for vascular disease
-
Poddar R, Sivasubramanian N, DiBello PM, et al. Homocysteine induces expression and secretion of monocyte chemoattractant protein-And interleukin-8 in human aortic endothelial cells: Implications for vascular disease. Circulation 2001;103:2717-23.
-
(2001)
Circulation
, vol.103
, pp. 2717-2723
-
-
Poddar, R.1
Sivasubramanian, N.2
Di Bello, P.M.3
-
96
-
-
14044276314
-
Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function
-
Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 2005;6:27-36.
-
(2005)
Curr Drug Metab
, vol.6
, pp. 27-36
-
-
Weiss, N.1
-
97
-
-
17344368557
-
Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells
-
Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 2074-2081
-
-
Majors, A.1
Ehrhart, L.A.2
Pezacka, E.H.3
-
98
-
-
0025095390
-
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
-
Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990;81:51-60.
-
(1990)
Atherosclerosis
, vol.81
, pp. 51-60
-
-
Brattstrom, L.1
Israelsson, B.2
Norrving, B.3
-
99
-
-
77957949167
-
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-Analysis of 8 randomized trials involving 37,485 individuals
-
Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-Analysis of 8 randomized trials involving 37,485 individuals. Arch Intern Med 2010;170:1622-31.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1622-1631
-
-
Clarke, R.1
Halsey, J.2
Lewington, S.3
-
100
-
-
49949101867
-
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial
-
Ebbing M, Bleie O, Ueland PM, et al.Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 2008;300:795-804.
-
(2008)
JAMA
, vol.300
, pp. 795-804
-
-
Ebbing, M.1
Bleie, O.2
Ueland, P.M.3
-
101
-
-
33645753544
-
Homocysteine lowering with folic acid and B vitamins in vascular disease
-
Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354: 1567-77.
-
(2006)
N Engl J Med
, vol.354
, pp. 1567-1577
-
-
Lonn, E.1
Yusuf, S.2
Arnold, M.J.3
-
102
-
-
84868518564
-
Alteration in lipoproteinassociated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers
-
Ostadal P, Vondrakova D, Kruger A, et al. Alteration in lipoproteinassociated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers. Lipids Health Dis 2012;11:153.
-
(2012)
Lipids Health Dis
, vol.11
, pp. 153
-
-
Ostadal, P.1
Vondrakova, D.2
Kruger, A.3
-
103
-
-
82955212740
-
Decreased circulating lipoprotein-Associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome
-
Dohi T, Miyauchi K, Okazaki S, et al. Decreased circulating lipoprotein-Associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome. Atherosclerosis 2011;219:907-12.
-
(2011)
Atherosclerosis
, vol.219
, pp. 907-912
-
-
Dohi, T.1
Miyauchi, K.2
Okazaki, S.3
-
104
-
-
43049122963
-
The effect of darapladib on plasma lipoprotein-Associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: The results of a multicenter, randomized, double-blind, placebo-controlled study
-
Mohler ER III, Ballantyne CM, Davidson MH, et al. The effect of darapladib on plasma lipoprotein-Associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: The results of a multicenter, randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2008;51:1632-41.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1632-1641
-
-
Mohler III, E.R.1
Ballantyne, C.M.2
Davidson, M.H.3
-
105
-
-
54049152760
-
Effects of the direct lipoprotein-Associated phospholipase A (2) inhibitor darapladib on human coronary atherosclerotic plaque
-
Serruys PW, Garcia-Garcia HM, Buszman P, et al. Effects of the direct lipoprotein-Associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118:1172-82.
-
(2008)
Circulation
, Issue.118
, pp. 1172-1182
-
-
Serruys, P.W.1
Garcia-Garcia, H.M.2
Buszman, P.3
-
106
-
-
0023029454
-
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
-
Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-38.
-
(1986)
JAMA
, vol.256
, pp. 2835-2838
-
-
Castelli, W.P.1
Garrison, R.J.2
Wilson, P.W.3
-
107
-
-
0024501678
-
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective american studies
-
Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
-
(1989)
Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
Probstfield, J.L.2
Garrison, R.J.3
-
108
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl JMed 2007;357:2109-22.
-
(2007)
N Engl JMed
, vol.357
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
-
109
-
-
84870045994
-
Effects of dalcetrapib in patients with a recent acute coronary syndrome
-
dal-OUTCOMES Investigators
-
Schwartz GG, Olsson AG, Abt M, et al; dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-99.
-
(2012)
N Engl J Med
, vol.367
, pp. 2089-2099
-
-
Schwartz, G.G.1
Olsson, A.G.2
Abt, M.3
-
110
-
-
84855171302
-
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
-
AIM-HIGH Investigators
-
AIM-HIGH Investigators, Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255-67.
-
(2011)
N Engl J Med
, vol.365
, pp. 2255-2267
-
-
Boden, W.E.1
Probstfield, J.L.2
-
111
-
-
38749102779
-
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk: The IDEAL and EPIC-Norfolk studies
-
van der Steeg WA, Holme I, Boekholdt SM, et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk: The IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol 2008;51:634-42.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 634-642
-
-
Van Der Steeg, W.A.1
Holme, I.2
Boekholdt, S.M.3
-
112
-
-
0022272843
-
AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission
-
Gualandri V, Franceschini G, Sirtori CR, et al. AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet 1985;37:1083-97.
-
(1985)
Am J Hum Genet
, vol.37
, pp. 1083-1097
-
-
Gualandri, V.1
Franceschini, G.2
Sirtori, C.R.3
-
113
-
-
0035901577
-
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: The Limone sul Garda study
-
Sirtori CR, Calabresi L, Franceschini G, et al. Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: The Limone sul Garda study. Circulation 2001;103:1949-54.
-
(2001)
Circulation
, vol.103
, pp. 1949-1954
-
-
Sirtori, C.R.1
Calabresi, L.2
Franceschini, G.3
-
114
-
-
84155166795
-
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-Type)
-
Ibanez B, Giannarelli C, Cimmino G, et al. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-Type). Atherosclerosis 2012;220:72-77.
-
(2012)
Atherosclerosis
, vol.220
, pp. 72-77
-
-
Ibanez, B.1
Giannarelli, C.2
Cimmino, G.3
-
115
-
-
0242577955
-
Effect of recombinant ApoAI Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial
-
Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoAI Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA 2003;290:2292-300.
-
(2003)
JAMA
, vol.290
, pp. 2292-2300
-
-
Nissen, S.E.1
Tsunoda, T.2
Tuzcu, E.M.3
-
116
-
-
78651379500
-
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
-
Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011;364:127-35.
-
(2011)
N Engl J Med
, vol.364
, pp. 127-135
-
-
Khera, A.V.1
Cuchel, M.2
De La Llera-Moya, M.3
-
117
-
-
0041352835
-
Asymptomatic cardiac disease following mediastinal irradiation
-
Heidenreich PA, Hancock SL, Lee BK, et al. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003;42: 743-9.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 743-749
-
-
Heidenreich, P.A.1
Hancock, S.L.2
Lee, B.K.3
-
118
-
-
4143078308
-
Cardiovascular status in long-Term survivors of Hodgkin's disease treated with chest radiotherapy
-
Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-Term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-48.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3139-3148
-
-
Adams, M.J.1
Lipsitz, S.R.2
Colan, S.D.3
-
119
-
-
33748650989
-
Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment
-
Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 2006;24:4100-06.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4100-4106
-
-
Harris, E.E.1
Correa, C.2
Hwang, W.T.3
-
120
-
-
33847760275
-
Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study
-
Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst 2007;99:206-14.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 206-214
-
-
Swerdlow, A.J.1
Higgins, C.D.2
Smith, P.3
-
121
-
-
0027249771
-
Severe coronary artery disease after radiation therapy of the chest and mediastinum: Clinical presentation and treatment
-
Orzan F, Brusca A, Conte MR, et al. Severe coronary artery disease after radiation therapy of the chest and mediastinum: Clinical presentation and treatment. Br Heart J 1993;69:496-500.
-
(1993)
Br Heart J
, vol.69
, pp. 496-500
-
-
Orzan, F.1
Brusca, A.2
Conte, M.R.3
-
122
-
-
84856736863
-
Distribution of coronary artery stenosis after radiation for breast cancer
-
Nilsson G, Holmberg L, Garmo H, et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol 2012;30:380-6.
-
(2012)
J Clin Oncol
, vol.30
, pp. 380-386
-
-
Nilsson, G.1
Holmberg, L.2
Garmo, H.3
-
123
-
-
34250703560
-
Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease
-
Heidenreich PA, Schnittger I, Strauss HW, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007;25:43-9.
-
(2007)
J Clin Oncol
, vol.25
, pp. 43-49
-
-
Heidenreich, P.A.1
Schnittger, I.2
Strauss, H.W.3
-
124
-
-
73149101321
-
Relation of coronary artery calcium score to premature coronary artery disease in survivors .15 years of Hodgkin's lymphoma
-
Andersen R, Wethal T, Gunther A, et al. Relation of coronary artery calcium score to premature coronary artery disease in survivors .15 years of Hodgkin's lymphoma. Am J Cardiol 2010;105:149-52.
-
(2010)
Am J Cardiol
, vol.105
, pp. 149-152
-
-
Andersen, R.1
Wethal, T.2
Gunther, A.3
-
125
-
-
84863915229
-
The prevention of cardiovascular disease in cancer survivors
-
Daher IN, Daigle TR, Bhatia N, et al. The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J 2012;39:190-8.
-
(2012)
Tex Heart Inst J
, vol.39
, pp. 190-198
-
-
Daher, I.N.1
Daigle, T.R.2
Bhatia, N.3
-
126
-
-
46449120787
-
Coronary artery disease after radiation therapy for Hodgkin's lymphoma: Coronary CT angiography findings and calcium scores in nine asymptomatic patients
-
Rademaker J, Schoder H, Ariaratnam NS, et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: Coronary CT angiography findings and calcium scores in nine asymptomatic patients. AJR Am J Roentgenol 2008;191:32-7.
-
(2008)
AJR Am J Roentgenol
, vol.191
, pp. 32-37
-
-
Rademaker, J.1
Schoder, H.2
Ariaratnam, N.S.3
-
127
-
-
32944462609
-
Cardiac morbidity of adjuvant radiotherapy for breast cancer
-
Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 2005;23:7475-82.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7475-7482
-
-
Patt, D.A.1
Goodwin, J.S.2
Kuo, Y.F.3
-
128
-
-
0025374837
-
Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish cancer registry
-
Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish cancer registry. Br J Cancer 1990;61:866-8.
-
(1990)
Br J Cancer
, vol.61
, pp. 866-868
-
-
Rutqvist, L.E.1
Johansson, H.2
-
129
-
-
22944477780
-
Long-Term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER Cancer Registries
-
Darby SC, McGale P, Taylor CW, et al. Long-Term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER Cancer Registries. Lancet Oncol 2005;6:557-65.
-
(2005)
Lancet Oncol
, vol.6
, pp. 557-565
-
-
Darby, S.C.1
McGale, P.2
Taylor, C.W.3
|